64cu-atsm
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00794339)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Payload
- 64-copper
Oral
No
Parenteral
No
Topical
No
Also known as
- 64cu-atsm
- 64cu-atsm
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03951337 | Phase 2 | Apr 26, 2019 | Fondation ARC, Institut de Cancerologie de l'Ouest Paul Papin |
| NCT01006226 | N/A | Oct 29, 2009 | Washington University in St. Louis |
| NCT00794339 | Phase 2 | Jul 1, 2009 | American College of Radiology, National Cancer Institute (NCI), University of Washington, Washington University in St. Louis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Washington University in St. Louis | Academic/Hospital | 2 | 1 | 2 | 2009 |
| American College of Radiology | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Fondation ARC | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Institut de Cancerologie de l'Ouest Paul Papin | Academic/Hospital | 1 | 1 | 1 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2009 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2009 |
6 organizations
Page 1 / 1